COMPANY
Company history
“ Korean Drug Co. Ltd is a company that challenges the future with unprecedented growth and development ”
2010 ~ 2019
-
2019
Nov.Designation as a company applying good manufacturing practice (GMP) for health functional food.
-
2016
Jul.National research funding of KRW 550 million for development of new functional food ingredients in the use of Portulaca extracts.
-
2015
Nov.Investment of 5% in share of "DIAMESCO Co, Ltd.', digital insulin pen development company.
Sept.National research funding of KRW 1.2 billion for atopic dermatitis research.
-
2014
Jul.Selection of the Agricultural biotechnology development business with utilizing common sage for osteoporosis treatment business, national research funding of KRW 5 billion